MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED
Quick Take
- • Trading at 23.9× trailing earnings
- • Moderate ROE at 13.2%
- • Leveraged balance sheet (D/E 1.28)
- • No dividend data
- • Operating margin 21.3% · Net margin 6.3%
- • Profit growth +21.10% YoY · Beta —
Latest quarter · Jun 2025
| ₹ Cr | Jun 2025 | QoQ | YoY |
|---|---|---|---|
| Revenue | 23 | — | — |
| Operating Profit | 6 | — | — |
| Net Profit | 3 | — | — |
| EPS (₹) | 1.99 | — | — |
Shareholding Pattern
About the company
From latest AR & concallModern Diagnostic & Research Centre Limited provides diagnostic and related healthcare tests services to individuals, healthcare institutions, doctors, corporates and other institutional customers in India. It offers lab services, which includes molecular diagnostics and oncogenomics, cytogenetics, histopathology and cytopathology, microbiology, hematology and coagulation, biochemistry, allergy testing, serology and immunology, hormonal assays, cervical cancer screening, maternal screening markers, clinical pathology, autoimmune profile services. The company also provides radiology services, such as magnetic resonance imaging, computerized tomography scan (CT) scans, PET-CT, ultrasound, cardiology, color Doppler studies, digital X-rays, mammography, bone screen, Nerve conduction velocity, interventional radiology, heart lab, neuro lab and laboratory, electrocardiogram, cone beam CT, orthopantomogram, pulmonary function tests, etc. In addition, it offers Specialised Genetic & Molecular Services. The company was founded in 1985 and is based in Gurugram, India.
